134 related articles for article (PubMed ID: 7183426)
1. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
Kuang PG
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
[No Abstract] [Full Text] [Related]
2. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
[No Abstract] [Full Text] [Related]
3. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
[TBL] [Abstract][Full Text] [Related]
4. Serum dopamine-beta-hydroxylase activity in schizophrenia.
Meltzer HY; Nasr SJ; Tong C
Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
[TBL] [Abstract][Full Text] [Related]
5. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
Lipcsey A
Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
[No Abstract] [Full Text] [Related]
6. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
Arató M; Bagdy G; Perényi A
Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
[No Abstract] [Full Text] [Related]
7. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
Xavier Vieira R; Azevedo M; Polónio P; Manso C
Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
[No Abstract] [Full Text] [Related]
8. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
Baron M; Levitt M; Asnis L; Fein M
Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
[No Abstract] [Full Text] [Related]
9. Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia.
Markianos M; Rinieris P; Hatzimanolis J; Stefanis C
Biol Psychiatry; 1990 May; 27(10):1176-8. PubMed ID: 2340326
[No Abstract] [Full Text] [Related]
10. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
[TBL] [Abstract][Full Text] [Related]
11. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
[No Abstract] [Full Text] [Related]
12. Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders.
Wetterberg L; Aberg H; Ross SB; Frödén O
Scand J Clin Lab Invest; 1972 Nov; 30(3):283-9. PubMed ID: 4264461
[No Abstract] [Full Text] [Related]
13. Plasma DBH activity: relation to genetic factors in schizophrenia.
Baron M; Levitt M; Perlman R
Commun Psychopharmacol; 1980; 4(3):197-202. PubMed ID: 7226750
[No Abstract] [Full Text] [Related]
14. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics.
Arató M; Bagdy G; Blümel F; Perényi A; Rihmer Z
Pharmacopsychiatria; 1983 Jan; 16(1):19-22. PubMed ID: 6828551
[TBL] [Abstract][Full Text] [Related]
15. [The possible role of dopamine beta-monooxygenase in the pathogenesis of schizophrenia].
Mailian KR; Boiadzhian AS; Melik-Pashaian MA; Aĭvazian VA; Karagezian KG
Dokl Akad Nauk; 1995 Jun; 342(6):833-4. PubMed ID: 7580969
[No Abstract] [Full Text] [Related]
16. [Comparative studies of various clinical and psychopharmacological parameters of schizoaffective psychosis and paranoid schizophrenia].
Masiak M; Perzyński J; Nagay J; Marmurowska-Michałowska H; Olajossy M; Wysocka A
Psychiatr Pol; 1990; 24(5):1-9. PubMed ID: 2131470
[TBL] [Abstract][Full Text] [Related]
17. [Study of the plasma activity of dopamine-beta-hydroxylase in patients with arterial hypertension].
Sega R; Algeri S; Recchia M; Palermo A; Branciforti A; Braibanti E; Libretti A
Boll Soc Ital Cardiol; 1976; 21(8):1311-9. PubMed ID: 801333
[No Abstract] [Full Text] [Related]
18. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
[TBL] [Abstract][Full Text] [Related]
19. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
Meltzer HY; Tong C; Luchins DJ
Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
